The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|October 24, 2013
SGS Life Science Services Opens Center of Excellence for Biophysical Analysis
Author(s)Pharmaceutical Technology Editors
SGS Life Science Services opens a Center of Excellence for Biophysical Analysis in the UK.
Advertisement
SGS Life Science Services has completed the development of a Center for Excellence for biophysical analysis of biopharmaceutical products in its SGS M-Scan facility in Wokingham, the United Kingdom.
The biophysical analysis group is lead by Dr.Iñigo Rodriguez-Mendieta, who along with his team, provides expertise in higher order structure analysis. The team can perform aggregation analysis, secondary/tertiary structural analysis, and thermal stability assessment and comparison. The new center complements the company's recent investment, announced in March 2013, to develop integrated formulation and stability testing services at the Wokingham facility, slated for completion in the fourth quarter 2013 and to be fully validated by early 2014.
Advertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement